These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 28766687)
41. Long noncoding RNA HEGBC promotes tumorigenesis and metastasis of gallbladder cancer via forming a positive feedback loop with IL-11/STAT3 signaling pathway. Yang L; Gao Q; Wu X; Feng F; Xu K J Exp Clin Cancer Res; 2018 Aug; 37(1):186. PubMed ID: 30086773 [TBL] [Abstract][Full Text] [Related]
42. Expression and functional characterization of INPP4B in gallbladder cancer patients and gallbladder cancer cells. Wu Y; Meng D; Xu X; Bao J; You Y; Sun Y; Li Y; Sun D BMC Cancer; 2021 Apr; 21(1):433. PubMed ID: 33879096 [TBL] [Abstract][Full Text] [Related]
43. PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2. Shen H; Zhan M; Zhang Y; Huang S; Xu S; Huang X; He M; Yao Y; Man M; Wang J Cell Death Dis; 2018 Jan; 9(2):71. PubMed ID: 29358655 [TBL] [Abstract][Full Text] [Related]
44. Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway. Xu J; Zhang S; Wang R; Wu X; Zeng L; Fu Z Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28432271 [TBL] [Abstract][Full Text] [Related]
45. EIF3D promotes gallbladder cancer development by stabilizing GRK2 kinase and activating PI3K-AKT signaling pathway. Zhang F; Xiang S; Cao Y; Li M; Ma Q; Liang H; Li H; Ye Y; Zhang Y; Jiang L; Hu Y; Zhou J; Wang X; Zhang Y; Nie L; Liang X; Gong W; Liu Y Cell Death Dis; 2017 Jun; 8(6):e2868. PubMed ID: 28594409 [TBL] [Abstract][Full Text] [Related]
46. Tumor suppressor LKB1 inhibits the progression of gallbladder carcinoma and predicts the prognosis of patients with this malignancy. Hu MT; Wang JH; Yu Y; Liu C; Li B; Cheng QB; Jiang XQ Int J Oncol; 2018 Sep; 53(3):1215-1226. PubMed ID: 30015925 [TBL] [Abstract][Full Text] [Related]
47. KIF15 knockdown suppresses gallbladder cancer development. Wang J; Wang D; Fei Z; Feng D; Zhang B; Gao P; Hu G; Li W; Huang X; Chen D; Ding X; Wu W Eur J Cell Biol; 2021; 100(7-8):151182. PubMed ID: 34781077 [TBL] [Abstract][Full Text] [Related]
48. Depletion of the triggering receptor expressed on myeloid cells 2 inhibits progression of renal cell carcinoma via regulating related protein expression and PTEN-PI3K/Akt pathway. Zhang H; Sheng L; Tao J; Chen R; Li Y; Sun Z; Qian W Int J Oncol; 2016 Dec; 49(6):2498-2506. PubMed ID: 27779645 [TBL] [Abstract][Full Text] [Related]
49. Long non-coding RNA MINCR promotes gallbladder cancer progression through stimulating EZH2 expression. Wang SH; Yang Y; Wu XC; Zhang MD; Weng MZ; Zhou D; Wang JD; Quan ZW Cancer Lett; 2016 Sep; 380(1):122-33. PubMed ID: 27345740 [TBL] [Abstract][Full Text] [Related]
50. HASPIN is involved in the progression of gallbladder carcinoma. Zhu D; Gu X; Lin Z; Yu D; Wang J; Li L Exp Cell Res; 2020 May; 390(2):111863. PubMed ID: 31987787 [TBL] [Abstract][Full Text] [Related]
51. Long noncoding RNA MEG3 regulates LATS2 by promoting the ubiquitination of EZH2 and inhibits proliferation and invasion in gallbladder cancer. Jin L; Cai Q; Wang S; Wang S; Mondal T; Wang J; Quan Z Cell Death Dis; 2018 Oct; 9(10):1017. PubMed ID: 30282996 [TBL] [Abstract][Full Text] [Related]
52. Overexpression of LncRNA AFAP1-AS1 predicts poor prognosis and promotes cells proliferation and invasion in gallbladder cancer. Ma F; Wang SH; Cai Q; Zhang MD; Yang Y; Ding J Biomed Pharmacother; 2016 Dec; 84():1249-1255. PubMed ID: 27810781 [TBL] [Abstract][Full Text] [Related]
53. miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1. Lu W; Hu Y; Ma Q; Zhou L; Jiang L; Li Z; Zhao S; Xu Y; Shi W; Li S; Liu Y Oncotarget; 2016 Sep; 7(38):62364-62376. PubMed ID: 27577078 [TBL] [Abstract][Full Text] [Related]
54. Identification of MAP kinase pathways as therapeutic targets in gallbladder carcinoma using targeted parallel sequencing. Li M; Chen L; Qu Y; Sui F; Yang Q; Ji M; Shi B; Chen M; Hou P Oncotarget; 2017 May; 8(22):36319-36330. PubMed ID: 28422736 [TBL] [Abstract][Full Text] [Related]
55. Overexpressed microRNA-136 works as a cancer suppressor in gallbladder cancer through suppression of JNK signaling pathway via inhibition of MAP2K4. Niu J; Li Z; Li F Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G670-G681. PubMed ID: 31369289 [TBL] [Abstract][Full Text] [Related]
56. The lncRNA MALAT1 functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-363-3p in gallbladder cancer. Wang SH; Zhang WJ; Wu XC; Weng MZ; Zhang MD; Cai Q; Zhou D; Wang JD; Quan ZW J Cell Mol Med; 2016 Dec; 20(12):2299-2308. PubMed ID: 27420766 [TBL] [Abstract][Full Text] [Related]
57. cIAP2 promotes gallbladder cancer invasion and lymphangiogenesis by activating the NF-κB pathway. Jiang X; Li C; Lin B; Hong H; Jiang L; Zhu S; Wang X; Tang N; Li X; She F; Chen Y Cancer Sci; 2017 Jun; 108(6):1144-1156. PubMed ID: 28295868 [TBL] [Abstract][Full Text] [Related]
58. ELF3 suppresses gallbladder cancer development through downregulation of the EREG/EGFR/mTOR complex 1 signalling pathway. Nakamura T; Nishikawa Y; Shiokawa M; Takeda H; Yokode M; Matsumoto S; Muramoto Y; Ota S; Yoshida H; Okada H; Kuwada T; Marui S; Matsumori T; Maruno T; Uza N; Kodama Y; Hatano E; Seno H J Pathol; 2023 Sep; 261(1):28-42. PubMed ID: 37345534 [TBL] [Abstract][Full Text] [Related]
59. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway. Wang Y; Zhao M; Liu J; Sun Z; Ni J; Liu H Oncol Rep; 2017 Sep; 38(3):1715-1723. PubMed ID: 28713974 [TBL] [Abstract][Full Text] [Related]
60. TNF-alpha promotes lymphangiogenesis and lymphatic metastasis of gallbladder cancer through the ERK1/2/AP-1/VEGF-D pathway. Hong H; Jiang L; Lin Y; He C; Zhu G; Du Q; Wang X; She F; Chen Y BMC Cancer; 2016 Mar; 16():240. PubMed ID: 26992854 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]